AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
36 hedge funds and large institutions have $182M invested in Agile Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
36
Holding in Top 10
2
Calls
$50K
Puts
–
Top Buyers
| 1 | +$953K | |
| 2 | +$96.1K | |
| 3 | +$42K | |
| 4 |
PFM
Parsec Financial Management
Asheville,
North Carolina
|
+$14.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.7K |
Top Sellers
| 1 | -$358K | |
| 2 | -$171K | |
| 3 | -$129K | |
| 4 |
VF
Virtu Financial
New York
|
-$116K |
| 5 |
Jane Street
New York
|
-$37K |